P/E ratio for Neogen (NEOG)

P/E ratio history for Neogen from 2001 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
PerkinElmer PKI	15.0	-1,303.10%	🇺🇸 USA
IDEXX Laboratories IDXX	56.2	-4,616.41%	🇺🇸 USA
Illumina ILMN	28.9	-2,419.14%	🇺🇸 USA
Pacific Biosciences PACB	-1.41	13.01%	🇺🇸 USA
Meridian Bioscience VIVO	35.0	-2,915.16%	🇺🇸 USA
Thermo Fisher Scientific TMO	33.0	-2,755.28%	🇺🇸 USA
Danaher DHR	46.4	-3,826.91%	🇺🇸 USA
Becton Dickinson BDX	34.8	-2,899.22%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.